Skip to main content

Table 4 Univariate Cox Regression for recurrence using the EORTC score, stratified by treatment subgroups

From: Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer

 

95.0% CI for HR

Group

P-Value

Hazard Ratio

Lower

Upper

Whole Cohort

0.132

1.085

0.976

1.207

No Treatment

0.024

1.278

1.033

1.580

MMC

0.266

1.128

0.913

1.393

BCG

0.934

1.008

0.841

1.207

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us